This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
Europe's premier partnering event
November 3–5, 2025 | Vienna, AustriaNovember 11–12, 2025 | Digital Partnering
Menu
The Power of Presenting at Biotech Showcase
By EBD GroupShareshare

Biotech Showcase™ provides a key platform where companies can showcase their innovative assets and build their profile with potential investors and strategic partners. Informa Pharma Intelligence analysts took a deep dive into what has happened to companies who have presented at Biotech Showcase. What they discovered is astonishing and in this free infographic!

Learn how:

  • In just the past five years, 250 companies that presented at Biotech Showcase have generated deals worth over $61bn
  • 26 companies went public with $1.7bn+ total disclosed IPOs
  • 29 companies were acquired for $7.9bn+ total potential value

Infographic URL banner

Register to attend and for the opportunity to become a Biotech Showcase presenter on January 13–15, 2020 at the Hilton San Francisco Union Square.

Startups
Drug Dev
Events
Innovation

Related news

Innovation

Interview: Promoting prosperity in the life science sectors of China and the UK

In this exclusive interview, Her Majesty’s Trade Commissioner for China at the Department for International Trade, John Edwards, discusses how China’s healthcare and life sciences markets are growing rapidly and are driven by increased demand and changes to regulations, plus much more.
Drug Development

Interview: Importance of diversity and partnering in global life sciences

ATLATL Innovation Cluster (IC) in the heart of Zhangjiang Pharma Valley. Its Founder and CEO, Dr. P.C. Zhu, designed it to be a launchpad for high-potential life sciences in China. In this interview with EBD Group he discusses the opportunities ATLATL provides and the importance of partnering in the life science industry.
Drug Development

Video Interview - Johnson & Johnson’s approach to external innovation

William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence, ahead of ChinaBio® Partnering Forum Digital.
Drug Development

Interview – J&J’s multi-pronged approach to life science innovation, partnerships, and advanced technologies

Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.